Answers are grounded in this paper and cite their sources.
Preclinical knockout study reveals sex-specific vascular compensation in eNOS/COX-1-deficient mice, indicating endothelium-derived hyperpolarizing factor protects females from hypertension.
Background— Endothelium-dependent dilatation is mediated by 3 principal vasodilators: nitric oxide (NO), prostacyclin (PGI 2 ), and endothelium-derived hyperpolarizing factor (EDHF). To determine the relative contribution of these factors in endothelium-dependent relaxation, we have generated mice in which the enzymes required for endothelial NO and PGI 2 production, endothelial NO synthase (eNOS) and cyclooxygenase-1 (COX-1), respectively, have been disrupted (eNOS −/− and COX-1 −/− mice). Methods and Results— In female mice, the absence of eNOS and COX-1 had no effect on mean arterial blood pressure (BP), whereas BP was significantly elevated in eNOS −/− /COX-1 −/− males compared with wild-type controls. Additionally, endothelium-dependent relaxation remained intact in the resistance vessels of female mice and was associated with vascular smooth muscle hyperpolarization; however, these responses were profoundly suppressed in arteries of male eNOS −/− /COX-1 −/− animals. Similarly, the endothelium-dependent vasodilator bradykinin produced dose-dependent hypotension in female eNOS −/− /COX-1 −/− animals in vivo but had no effect on BP in male mice. Conclusions— These studies indicate that EDHF is the predominant endothelium-derived relaxing factor in female mice, whereas NO and PGI 2 are the predominant mediators in male mice. Moreover, the gender-specific prevalence of EDHF appears to underlie the protection of female eNOS −/− /COX-1 −/− mice against hypertension.
No takes yet. Share an insight, caveat, or question.
Scotland et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: